These findings support a critical role for <i>BRCA1P1</i> in regulating innate immune defense and antitumor responses across cancer types, suggesting that targeting pseudogene-derived RNAs may offer innovative therapeutic strategies to enhance antitumor immunity in breast and other cancers. The gene discussed is BRCA1P1; the disease is cancer.